Mantle cell lymphoma (MCL) accounts for 5-6% of non-Hodgkin lymphomas, with characteristic expression of cyclin D1 due to CCND1-IGH gene rearrangement. This evidence concerns the gene CCND1 and mantle cell lymphoma.